Notice of Intent To Grant Exclusive Patent License; Ultratrace Detection, LLC, 5289-5290 [2010-2119]

Download as PDF Federal Register / Vol. 75, No. 21 / Tuesday, February 2, 2010 / Notices with the Scientific Advisory Board at the time and in the manner permitted by the Board. DATES: The meeting will be held: Tuesday, March 2, 2010 from 8:30 a.m. to 5 p.m. Wednesday, March 3, 2010 from 9 a.m. to 5 p.m. Thursday, March 4, 2010 from 8 a.m. to 10 a.m. ADDRESSES: The meeting will be held at the Estancia La Jolla Hotel, 9700 N. Torrey Pines Road, La Jolla, CA 92037. FOR FURTHER INFORMATION CONTACT: Mr. Jonathan Bunger, SERDP Office, 901 North Stuart Street, Suite 303, Arlington, VA or by telephone at (703) 696–2126. Dated: January 27, 2010. Mitchell S. Bryman, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2010–2049 Filed 2–1–10; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Office of the Secretary Defense Health Board (DHB) Meeting Department of Defense (DoD). Notice of meeting. AGENCY: mstockstill on DSKH9S0YB1PROD with NOTICES ACTION: SUMMARY: Pursuant to the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix as amended), the Sunshine in the Government Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.150, and in accordance with section 10(a)(2) of Public Law, DoD announces that the Defense Health Board (DHB or Board) will meet on March 1–2, 2010, to address and deliberate pending and new Board issues and provide briefings for Board members on topics related to ongoing Board business. DATES: The meetings will be held on March 1 from 7 a.m. to 5 p.m. and on March 2 from 7 a.m. to 2 p.m. The meeting is open to the public on March 1 from 9:15 a.m. to 12:30 p.m. and from 1:45 p.m. to 5 p.m. The Board will hold closed Administrative Working Meetings on March 1 from 9:15 a.m. to 12:30 p.m. and from 1:45 p.m. to 5 p.m. and on March 2 from 7 a.m. to 2 p.m. ADDRESSES: The meeting will be held at the Doubletree Hotel Cocoa Beach, 2080 North Atlantic Avenue, Cocoa Beach, Florida 32931. Written statements may be mailed to the address under FOR FURTHER INFORMATION CONTACT, e-mailed to dhb@ha.osd.mil or faxed to (703) 681– 3317. VerDate Nov<24>2008 16:52 Feb 01, 2010 Jkt 220001 FOR FURTHER INFORMATION CONTACT: Commander Edmond F. Feeks, Executive Secretary, Defense Health Board, Five Skyline Place, 5111 Leesburg Pike, Suite 810, Falls Church, Virginia 22041–3206, (703) 681–8448, EXT. 1228, Fax: (703) 681–3317, edmond.feeks@tma.osd.mil. SUPPLEMENTARY INFORMATION: Agenda On March 1, 2010, the DHB will receive briefings on military health needs and priorities. The following Defense Health Board Subcommittees will present updates to the Board: National Capital Region Base Realignment and Closure, Department of Defense Task Force on the Prevention of Suicide by Members of the Armed Forces, Military/Occupational Health and Medical Surveillance, and the Psychological Health External Advisory Subcommittee. Additionally, the Board will receive a brief regarding Electronic Medical Records. The Board will also vote on new battlefield burn care guidelines in the Tactical Combat Casualty Care Curriculum. Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102–3.140 through 102–3.165 and subject availability of space, the Defense Health Board meeting from 9:15 a.m. to 12:30 p.m. and from 1:45 p.m. to 5 p.m. on March 1 is open to the public. The Board will conduct administrative sessions in concert with the meeting on March 1, 2010, and on March 2, 2010 (see DATES). Pursuant to 41 CFR 102–3.160, the administrative working meetings are closed to the public. Additional information, agenda updates, and meeting registration are available online at the Defense Health Board Web site, http://www.ha.osd.mil/ dhb. The public is encouraged to register for the meeting. Written Statements Any member of the public wishing to provide input to the Defense Health Board should submit a written statement in accordance with 41 CFR 102–3.140(c) and section 10(a)(3) of the Federal Advisory Committee Act, and the procedures described in this notice. Written statement should be no longer than two type-written pages and must address the following detail: The issue, discussion, and a recommended course of action. Supporting documentation may also be included as needed to establish the appropriate historical context and to provide any necessary background information. Individuals desiring to submit a written statement may do so through the PO 00000 Frm 00011 Fmt 4703 Sfmt 4703 5289 Board’s Designated Federal Officer (see ADDRESSES). If the written statement is not received at least 10 calendar days prior to the meeting, which is subject to this notice, then it may not be provided to or considered by the Defense Health Board until the next open meeting. The Designated Federal Officer will review all timely submissions with the Defense Health Board Chairperson, and ensure they are provided to members of the Defense Health Board before the meeting that is subject to this notice. After reviewing the written comments, the Chairperson and the Designated Federal Officer may choose to invite the submitter of the comments to orally present their issue during an open portion of this meeting or at a future meeting. The Designated Federal Officer, in consultation with the Defense Health Board Chairperson, may, if desired, allot a specific amount of time for members of the public to present their issues for review and discussion by the Defense Health Board. Special Accommodations If special accommodations are required to attend (sign language, wheelchair accessibility) please contact Ms. Lisa Jarrett at (703) 681–8448 EXT. 1280 by February 22, 2010. Dated: January 28, 2010. Mitchell S. Bryman, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2010–2164 Filed 2–1–10; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Department of the Navy Notice of Intent To Grant Exclusive Patent License; Ultratrace Detection, LLC Department of the Navy, DoD. Notice. AGENCY: ACTION: SUMMARY: The Department of the Navy hereby gives notice of its intent to grant to Ultratrace Detection, LLC a revocable, nonassignable, exclusive license to practice the field of use of a Preconcentrator Device for sampling, collecting, analyzing, and detecting chemicals, warfare agents, or drugs in the United States, the Governmentowned inventions described in U.S. Patent Application No. 11/542,453 entitled ‘‘Micro Scale Flow Through Sorbent Plate Collection Device’’, Navy Case No. 100,203 and U.S. Patent Application No. 12/406,756 entitled ‘‘Actively Cooled Vapor E:\FR\FM\02FEN1.SGM 02FEN1 5290 Federal Register / Vol. 75, No. 21 / Tuesday, February 2, 2010 / Notices Preconcentrator’’, Navy Case No. 99,832 and any continuations, divisionals or reissues thereof. The inventions are jointly owned with the University of Louisville Research Foundation, Inc. and the University of Louisville will jointly execute the license. DATES: Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than February 17, 2010. ADDRESSES: Written objections are to be filed with the Naval Research Laboratory, Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375– 5320. FOR FURTHER INFORMATION CONTACT: Rita Manak, Head, Technology Transfer Office, NRL Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375– 5320, telephone 202–767–3083. Due to U.S. Postal delays, please fax 202–404– 7920, e-mail: rita.manak@nrl.navy.mil or use courier delivery to expedite response. Authority: 35 U.S.C. 207, 37 CFR Part 404. Dated: January 26, 2010. A.M. Vallandingham, Lieutenant Commander, Judge Advocate General’s Corps, U.S. Navy, Federal Register Liaison Officer. [FR Doc. 2010–2119 Filed 2–1–10; 8:45 am] BILLING CODE 3810–FF–P DEPARTMENT OF DEFENSE Notice of Intent To Grant Exclusive Patent License; Applied Minerals, Inc. Department of the Navy, DoD. Notice. AGENCY: mstockstill on DSKH9S0YB1PROD with NOTICES SUMMARY: The Department of the Navy hereby gives notice of its intent to grant to Applied Minerals, Inc., a revocable, nonassignable, exclusive license to practice the field of use of building materials which means the use of Halloysite Microtubules for the elution of any and all substances from them as a biocide in building materials including but not limited to, grouts, cements, parging materials, stuccos, and mortars; and wallboards, and cellulosebased materials such as particleboard, paneling, medium density fiberboard (MDF) paneling, plywood, lumber, chipboard, and ceiling tile; and caulks, sealants and adhesives; and high pressure laminates, wall, counter top and floor coverings or components thereof; and ceramics, cultured marbles, and tiles; and non-cellulose (i.e. polymer) based wallpapers, paneling, VerDate Nov<24>2008 16:52 Feb 01, 2010 DATES: Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than February 17, 2010. Written objections are to be filed with the Naval Research Laboratory, Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375– 5320. ADDRESSES: Department of the Navy ACTION: and other wall, counter top, and floor coverings or components; and insulations; and the field of use of paint which means the use of Halloysite Microtubules for the elution of any and all substances in paints, sealers, fillers, varnishes, shellac, polyurethane coatings, and any and all ‘‘paint-like’’ coatings applied in liquid form to any and all surfaces for the beautification or protection of surfaces in structures or components thereof, including but not limited to, buildings, marine structures (including boats), furniture and other normally ‘‘painted’’ materials in the United States, the Government-owned inventions described in U.S. Patent No. 5,492,696: Controlled Release Microstructures, Navy Case No. 76,896.//U.S. Patent No. 5,651,976: Controlled Release of Active Agents Using Inorganic Tubules, Navy Case No. 76,652.//U.S. Patent No. 5,705,191: Sustained Delivery of Active Compounds from Tubules with Rational Control, Navy Case No. 77,037.//U.S. Patent No. 6,280,759: Method of Controlled Release and Controlled Release Microstructures, Navy Case No. 78,215 and any continuations, divisionals or re-issues thereof. Jkt 220001 FOR FURTHER INFORMATION CONTACT: Rita Manak, Head, Technology Transfer Office, NRL Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375– 5320, telephone 202–767–3083. Due to U.S. Postal delays, please fax 202–404– 7920, e-mail: rita.manak@nrl.navy.mil or use courier delivery to expedite response. (Authority: 35 U.S.C. 207, 37 CFR part 404) Dated: January 22, 2010. A.M. Vallandingham, Lieutenant Commander, Judge Advocate General’s Corps, U.S. Navy, Federal Register Liaison Officer. [FR Doc. 2010–2120 Filed 2–1–10; 8:45 am] BILLING CODE 3810–FF–P PO 00000 DEPARTMENT OF DEFENSE Department of the Navy Notice of the Record of Decision for the United States Marine Corps Grow the Force at Marine Corps Base Camp Lejeune, Marine Corps Air Station New River, and Marine Corps Air Station Cherry Point, NC Department of the Navy, DOD. Notice of Record of Decision. AGENCY: ACTION: SUMMARY: Pursuant to Section 102(2)(c) of the National Environmental Policy Act (NEPA) of 1969, 42 United States Code (U.S.C.) Section 4332(2)(c), the regulations of the Council on Environmental Quality (CEQ) for Implementing the Procedural Provisions of NEPA (40 Code of Federal Regulations [CFR] parts 1500–1508), the Department of the Navy NEPA regulations (32 CFR part 775), and the Marine Corps Environmental Compliance and Protection Manual, which is Marine Corps Order P5090.2A w/change 2 (MCO P5090.2A), the Department of the Navy (DON) announces its decision to implement the permanent incremental increase in personnel at Marine Corps Base (MCB) Camp Lejeune, Marine Corps Air Station (MCAS) New River, and MCAS Cherry Point, North Carolina. More specifically, this action includes: (1) New infrastructure construction (e.g. buildings, roads, utility lines); (2) demolition and/or upgrades to existing infrastructure; and (3) relocating existing units and personnel to consolidate and better support the combat missions. Implementation of this action will be accomplished as set out in the Preferred Alternative and described in the Final Environmental Impact Statement (Final EIS) of December 11, 2009. SUPPLEMENTARY INFORMATION: The complete text of the Record of Decision is available for public viewing on the project Web site at http:// www.growtheforcenc.com along with copies of the Final EIS and supporting documents. For further information, contact Grow the Force in North Carolina EIS Project Manager, Naval Facilities Engineering Command, MidAtlantic, Building C Room 3012, 6505 Hampton Blvd., Norfolk, VA 23508– 1278. Telephone: 757–322–4942. Dated: January 22, 2010. A.M. Vallandingham, Lieutenant Commander, Judge Advocate General’s Corps, U.S. Navy, Federal Register Liaison Officer. [FR Doc. 2010–2118 Filed 2–1–10; 8:45 am] BILLING CODE 3810–FF–P Frm 00012 Fmt 4703 Sfmt 9990 E:\FR\FM\02FEN1.SGM 02FEN1

Agencies

[Federal Register Volume 75, Number 21 (Tuesday, February 2, 2010)]
[Notices]
[Pages 5289-5290]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-2119]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Intent To Grant Exclusive Patent License; Ultratrace 
Detection, LLC

AGENCY: Department of the Navy, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to Ultratrace Detection, LLC a revocable, nonassignable, 
exclusive license to practice the field of use of a Pre-concentrator 
Device for sampling, collecting, analyzing, and detecting chemicals, 
warfare agents, or drugs in the United States, the Government-owned 
inventions described in U.S. Patent Application No. 11/542,453 entitled 
``Micro Scale Flow Through Sorbent Plate Collection Device'', Navy Case 
No. 100,203 and U.S. Patent Application No. 12/406,756 entitled 
``Actively Cooled Vapor

[[Page 5290]]

Preconcentrator'', Navy Case No. 99,832 and any continuations, 
divisionals or re-issues thereof. The inventions are jointly owned with 
the University of Louisville Research Foundation, Inc. and the 
University of Louisville will jointly execute the license.

DATES: Anyone wishing to object to the grant of this license must file 
written objections along with supporting evidence, if any, not later 
than February 17, 2010.

ADDRESSES: Written objections are to be filed with the Naval Research 
Laboratory, Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375-
5320.

FOR FURTHER INFORMATION CONTACT: Rita Manak, Head, Technology Transfer 
Office, NRL Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375-
5320, telephone 202-767-3083. Due to U.S. Postal delays, please fax 
202-404-7920, e-mail: rita.manak@nrl.navy.mil or use courier delivery 
to expedite response.

    Authority: 35 U.S.C. 207, 37 CFR Part 404.

    Dated: January 26, 2010.
A.M. Vallandingham,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, 
Federal Register Liaison Officer.
[FR Doc. 2010-2119 Filed 2-1-10; 8:45 am]
BILLING CODE 3810-FF-P